Skip to main content
SpringerLink
Log in

Approach to patients with HBV and HCV coinfection

  • Published:
Current Hepatitis Reports Aims and scope Submit manuscript

Abstract

Coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is not uncommon, based on the high prevalence of both infections and their shared routes of transmission. Coinfected patients have higher rates of acute liver failure, decompensated cirrhosis, and hepatocellular carcinoma than do their monoinfected counterparts and therefore present a unique challenge to the clinician. The serology and virology of HBV and HCV in coinfection are dynamic and have many different patterns. Interestingly, both viruses interact such that each virus inhibits the other, usually with one virus being dominant. The dominant virus should generally be the target of antiviral therapeutic intervention. Studies with limited numbers of patients have assessed the success of treatment with standard interferon alone and in conjunction with either ribavirin or lamivudine. Higher doses of interferon appear to be required for the best outcome. Treatment guidelines have not been established for patients coinfected with HBV and HCV; therefore, treatment decisions are often made on an individual basis. The epidemiology, natural history, and current management of patients with HBV and HCV coinfection are the focus of this updated review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Chiaramonte M, Stroffolini T, Vian A, et al.: Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis. Cancer 1999, 85:2132–2137.

    Article  PubMed  CAS  Google Scholar 

  2. Kaklamani E, Trichopoulos D, Tzonou A, et al.: Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991, 265:1974–1976.

    Article  PubMed  CAS  Google Scholar 

  3. Benvegnu L, Fattovich G, Noventa F, et al.: Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994, 74:2442–2448.

    Article  PubMed  CAS  Google Scholar 

  4. Crockett SD, Keeffe EB: Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection. Ann Clin Microbiol Antimicrob 2005, 4:13.

    Article  PubMed  Google Scholar 

  5. Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2007, 45:507–539.

    Article  PubMed  CAS  Google Scholar 

  6. Hepatitis C—global prevalence (update). Wkly Epidemiol Rec 1999, 74:425–427.

  7. Atanasova MV, Haydouchka IA, Zlatev SP, et al.: Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Minerva Gastroenterol Dietol 2004, 50:89–96.

    PubMed  CAS  Google Scholar 

  8. Chakravarti A, Verma V, Jain M, Kar P: Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital. Trop Gastroenterol 2005, 26:183–187.

    PubMed  Google Scholar 

  9. Liaw YF: Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995, 22(4 Pt 1):1101–1108.

    PubMed  CAS  Google Scholar 

  10. Gaeta GB, Stornaiuolo G, Precone DF, et al.: Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 2003, 39:1036–1041.

    Article  PubMed  Google Scholar 

  11. Raimondo G, Brunetto MR, Pontisso P, et al.: Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients. Hepatology 2006, 43:100–107.

    Article  PubMed  Google Scholar 

  12. Fong TL, Di Bisceglie AM, Waggoner JG, et al.: The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 1991, 14:64–67.

    Article  PubMed  CAS  Google Scholar 

  13. Crespo J, Lozano JL, de la Cruz F, et al.: Prevalence and significance of hepatitis C viremia in chronic active hepatitis B. Am J Gastroenterol 1994, 89:1147–1151.

    PubMed  CAS  Google Scholar 

  14. Shih CM, Lo SJ, Miyamura T, et al.: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol 1993, 67:5823–5832.

    PubMed  CAS  Google Scholar 

  15. Schuttler CG, Fielder N, Schmidt K, et al.: Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002, 37:855–862.

    Article  PubMed  CAS  Google Scholar 

  16. Lin L, Verslype C, van Pelt JF, et al.: Viral interaction and clinical implications of coinfection of hepatitis C virus with other hepatitis viruses. Eur J Gastroenterol Hepatol 2006, 18:1311–1319.

    Article  PubMed  Google Scholar 

  17. Chu CM, Sheen IS, Liaw YF: Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection. Scand J Gastroenterol 2004, 39:778–782.

    Article  PubMed  CAS  Google Scholar 

  18. Sheen IS, Liaw YF, Lin DY, Chu CM: Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: a multivariate analysis in a longitudinal follow-up study. J Infect Dis 1994, 170:358–361.

    PubMed  CAS  Google Scholar 

  19. Liu CJ, Liou JM, Chen DS, Chen PJ: Natural course and treatment of dual hepatitis B virus and hepatitis C virus infections. J Formos Med Assoc 2005, 104:783–791.

    PubMed  Google Scholar 

  20. Liaw YF, Chu CM, Chang-Chien CS, Wui CS: Simultaneous acute infections with hepatitis non-A, non-B, and B viruses. Dig Dis Sci 1982, 27:762–764.

    Article  PubMed  CAS  Google Scholar 

  21. Baginski I, Chemin I, Hantz O, et al.: Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion 1992, 32:215–220.

    Article  PubMed  CAS  Google Scholar 

  22. Mimms LT, Mosley JW, Hollinger FB, et al.: Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. BMJ 1993, 307:1095–1097.

    PubMed  CAS  Google Scholar 

  23. Chen SW, Lee TS, Hu CC, et al.: Simultaneously acute hepatitis B virus and C virus coinfection and subsequent chronic hepatitis C. Scand J Infect Dis 2007, 39:351–354.

    Article  PubMed  Google Scholar 

  24. Liaw YF: Hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. J Gastroenterol 2002, 37(Suppl 13):65–68.

    Article  PubMed  Google Scholar 

  25. Liaw YF, Lin SM, Sheen IS, Chu CM: Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg elimination. Infection 1991, 19:250–251.

    Article  PubMed  CAS  Google Scholar 

  26. Liaw YF, Chen YC, Sheen IS, et al.: Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection. Gastroenterology 2004, 126:1024–1029.

    Article  PubMed  Google Scholar 

  27. Liaw YF, Yeh CT, Tsai SL: Impact of acute hepatitis B virus superinfection on chronic hepatitis C virus infection. Am J Gastroenterol 2000, 95:2978–2980.

    Article  PubMed  CAS  Google Scholar 

  28. Coffin CS, Mulrooney-Cousins PM, Lee SS, Michalak TI, Swain MG: Profound suppression of chronic hepatitis C following superinfection with hepatitis B virus. Liver Int 2007, 27:722–726.

    Article  PubMed  Google Scholar 

  29. Mohamed Ael S, al Karawi MA, Mesa GA: Dual infection with hepatitis C and B viruses: clinical and histological study in Saudi patients. Hepatogastroenterology 1997, 44:1404–1406.

    Google Scholar 

  30. Chu CM, Sheen IS, Liaw YF: The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994, 107:189–195.

    PubMed  CAS  Google Scholar 

  31. Feray C, Gigou M, Samuel D, et al.: Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993, 104:549–555.

    PubMed  CAS  Google Scholar 

  32. Kew MC, Yu MC, Kedda MA, et al.: The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997, 112:184–187.

    Article  PubMed  CAS  Google Scholar 

  33. Liaw YF, Leung N, Guan R, et al.: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver Int 2005, 25:472–489.

    Article  PubMed  Google Scholar 

  34. de Franchis R, Hadengue A, Lau G, et al.: EASL International Consensus Conference on Hepatitis B. 13–14 September, 2002 Geneva, Switzerland. Consensus statement (long version). J Hepatol 2003, 39(Suppl 1):S3–S25.

    PubMed  Google Scholar 

  35. Keeffe EB, Dieterich DT, Han SH, et al.: A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 2006, 4:936–962.

    Article  PubMed  CAS  Google Scholar 

  36. Dienstag JL, McHutchison JG: American Gastroenterological Association technical review on the management of hepatitis C. Gastroenterology 2006, 130:231–264; quiz 214–237.

    Article  PubMed  Google Scholar 

  37. Strader DB, Wright T, Thomas DL, Seeff LB: Diagnosis, management, and treatment of hepatitis C. Hepatology 2004, 39:1147–1171.

    Article  PubMed  Google Scholar 

  38. Gehenot M, Marcellin P, Colin JF, et al.: Alpha interferon therapy in HBsAg positive patients with chronic hepatitis C. Hepatology 1995, 22(Suppl A):116A.

    Google Scholar 

  39. Weltman MD, Brotodihardjo A, Crewe EB, et al.: Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment. J Viral Hepat 1995, 2:39–45.

    Article  PubMed  CAS  Google Scholar 

  40. Guptan RC, Thakur V, Raina V, Sarin SK: Alpha-interferon therapy in chronic hepatitis due to active dual infection with hepatitis B and C viruses. J Gastroenterol Hepatol 1999, 14:893–898.

    Article  PubMed  CAS  Google Scholar 

  41. Villa E, Grottola A, Buttafoco P, et al.: High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am J Gastroenterol 2001, 96:2973–2977.

    PubMed  CAS  Google Scholar 

  42. Utili R, Zampino R, Bellopede P, et al.: Dual or single hepatitis B and C virus infections in childhood cancer survivors: long-term follow-up and effect of interferon treatment. Blood 1999, 94:4046–4052.

    PubMed  CAS  Google Scholar 

  43. Zignego AL, Fontana R, Puliti S, et al.: Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med Virol 1997, 51:313–318.

    Article  PubMed  CAS  Google Scholar 

  44. Liaw YF, Chien RN, Lin SM, et al.: Response of patients with dual hepatitis B virus and C virus infection to interferon therapy. J Interferon Cytokine Res 1997, 17:449–452.

    PubMed  CAS  Google Scholar 

  45. Fukuda R, Ishimura N, Niigaki M, et al.: Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999, 58:201–207.

    Article  PubMed  CAS  Google Scholar 

  46. Fukuda R, Ishimura N, Hamamoto S, et al.: Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down-regulation of type-I interferon receptor gene expression in the liver. J Med Virol 2001, 63:220–227.

    Article  PubMed  CAS  Google Scholar 

  47. Liu CJ, Chen PJ, Lai MY, et al.: Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology 2003, 37:568–576.

    Article  PubMed  CAS  Google Scholar 

  48. Hung CH, Lee CM, Lu SN, et al.: Combination therapy with interferon-alpha and ribavirin in patients with dual hepatitis B and hepatitis C virus infection. J Gastroenterol Hepatol 2005, 20:727–732.

    Article  PubMed  CAS  Google Scholar 

  49. Chuang WL, Dai CY, Chang WY, et al.: Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Antivir Ther 2005, 10:125–133.

    PubMed  CAS  Google Scholar 

  50. Urganci N, Gulec S, Dogan S, Nuhoglu A: Interferon and ribavirin treatment results of patients with HBV-HCV coinfection cured of childhood malignancies. Int J Infect Dis 2006, 10:453–457.

    Article  PubMed  CAS  Google Scholar 

  51. Yalcin K, Degertekin H, Yildiz F, Kilinc N: A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin. J Gastroenterol 2003, 38:796–800.

    Article  PubMed  CAS  Google Scholar 

  52. Marrone A, Zampino R, D’Onofrio M, et al.: Combined interferon plus lamivudine treatment in young patients with dual HBV (HBeAg positive) and HCV chronic infection. J Hepatol 2004, 41:1064–1065.

    Article  PubMed  CAS  Google Scholar 

  53. Chan HL, Leung NW, Hui AY, et al.: A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Ann Intern Med 2005, 142:240–250.

    PubMed  CAS  Google Scholar 

  54. Rautou PE, Asselah T, Saadoun D, et al.: Hepatitis C virus eradication followed by HBeAg to anti-HBe seroconversion after pegylated interferon-alpha2b plus ribavirin treatment in a patient with hepatitis B and C coinfection. Eur J Gastroenterol Hepatol 2006, 18:1019–1022.

    Article  PubMed  CAS  Google Scholar 

  55. Chen PJ: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C/hepatitis B co-infection and chronic hepatitis C. Available at www.clinicaltrials.gov, identifier: NCT00154869.

  56. United Network of Organ Sharing. Available at www.unos.org. Accessed August 2007.

  57. Huang EJ, Wright TL, Lake JR, et al.: Hepatitis B and C coinfections and persistent hepatitis B infections: clinical outcome and liver pathology after transplantation. Hepatology 1996, 23:396–404.

    Article  PubMed  CAS  Google Scholar 

  58. Rifai K, Wedemeyer H, Rosenau J, et al.: Longer survival of liver transplant recipients with hepatitis virus coinfections. Clin Transplant 2007, 21:258–264.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stanford University School of Medicine, 750 Welch Road, Suite 210, Palo Alto, CA, 94304, USA

    Emmet B. Keeffe

Authors
  1. Seth Crockett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmet B. Keeffe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emmet B. Keeffe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Crockett, S., Keeffe, E.B. Approach to patients with HBV and HCV coinfection. Curr hepatitis rep 7, 18–24 (2008). https://doi.org/10.1007/s11901-008-0017-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11901-008-0017-z

Keywords

Search

Navigation